Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion

Merck KGaA announced an $11.3 billion acquisition of Bio-Techne, a life sciences company, marking its largest deal since the 2015 purchase of Sigma-Aldrich for $17 billion. The transaction expands Merck's portfolio in research reagents, instruments, and related life science tools supplied to labs and medical institutions.